August 1, 2018, sees the official launch of the PReCIOUS project, financed by the Friuli Venezia Giulia Autonomous Region in the context of the 2014-2020 POR-FESR funds (activity 1.2.a.1) for a grant of € 95.491,28. The project is divided into
The “PReCIOUS” project, presented by Transactiva under the 2014-2010 POR FESR 1.2.A.1 call for proposals, was admitted among the eligible projects, ranking third.
On March 19, 2018 the “Dialogo sulle politiche di coesione” (local and regional dialogues on cohesion policy) event, organized by AICCRE (Italian Association for the Council of Municipalities and Regions of Europe) took place in Udine, at the Salone del
On thursday, 15 february 2018 the 4th project meeting brought together the protagonists of the oraCle project to review and discuss the work progress. The meeting begun in the morning at the University of Udine, where each project partner presented
The local and national press is talking about “oraCle: New integrated approach for the oral therapy of Crohn’s disease”. Many journals are spreading awareness towards this project. Here the press releases issued in the month of January, 2018. Diario di
The oraCle project is at the height of its activities. The scientific partners met at the University of Trieste, guests of the Department of Life Sciences, on October 12, 2017. For the purposes of a better and more effective sharing
The oraCle project is proceeding well. The project partners met in the second meeting, held on 19 June 2017 at the Biofarma SpA headquarters. The meeting, focused on the scientific side of oraCle, saw a useful confrontation on the technical aspects
The “oraCle: New integrated approach to the oral therapy of Crohn’s Disease” project has officially started on April 1st, 2017. The first project meeting brought together industrial and public partners in the definition of strategies and action plans to follow
In July 2017 Transactiva directed, as leader, a public-private partnership for the participation in the POR FESR 2014-2020 calls, (Activity 1.3.b) – for “R&D projects to be achieved through public-private partnerships – areas of specialization Maritime Technologies and Smart Health”.